SCHEMBL29700463

SCHEMBL29700463

COc1ccc(CCC(=O)O)cc1.COc1ccc(COC(C)=O)cc1

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 11/20 0.73
F2RL1 P55085 1/20 0.55
FFAR4 Q5NUL3 4/20 0.55
ALDH1A1 P00352 2/20 0.53
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
LMNA P02545 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SLC5A1 P13866 1/20 0.51
SLC5A2 P31639 1/20 0.51
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL1868801 0.87 ALDH1A1 (0.63) FFAR1ALDH1A1NPC1RAB9APOLB
SCHEMBL112518 0.87 ALDH1A1 (0.62) FFAR1F2RL1ALDH1A1NPC1RAB9A
SCHEMBL30792366 0.87 FFAR1 (0.81) FFAR1F2RL1FFAR4ALDH1A1NFKB1
SCHEMBL274471 0.87 FFAR1 (0.81) FFAR1F2RL1FFAR4ALDH1A1NFKB1
SCHEMBL1871228 0.87 ALDH1A1 (0.62) FFAR1F2RL1ALDH1A1NPC1RAB9A
SCHEMBL5250063 0.84 FFAR1 (1.00) FFAR1F2RL1FFAR4NPC1RAB9A
Anisole SCHEMBL5689485 0.84 ALDH1A1 (0.70) FFAR1ALDH1A1NPC1RAB9APOLB
E1501 SCHEMBL16568775 0.84 ALDH1A1 (0.76) FFAR1FFAR4ALDH1A1
Anisole SCHEMBL30496784 0.83 FFAR1 (0.70) FFAR1F2RL1FFAR4NPC1RAB9A
SCHEMBL19721780 0.82 ALDH1A1 (0.56) FFAR1ALDH1A1NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709515-A1 COMPOSITION Givaudan SA (CH) 2026-03-18 EP disclosed
US-12539261-B2 Encapsulated compositions GIVAUDAN SA (CH) 2026-02-03 US disclosed
US-20250387771-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES GIVAUDAN SA (CH) 2025-12-25 US disclosed
EP-4658741-A1 LAUNDRY CARE COMPOSITION Givaudan SA (CH) 2025-12-10 EP disclosed
US-20250345251-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-11-13 US disclosed
EP-4626594-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2025-10-08 EP disclosed
EP-4619496-A1 LAUNDRY COMPOSITION Givaudan SA (CH) 2025-09-24 EP disclosed
US-20250215359-A1 FABRIC CARE COMPOSITION GIVAUDAN SA (CH) 2025-07-03 US disclosed
EP-4557951-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES Givaudan SA (CH) 2025-05-28 EP disclosed
EP-4554405-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2025-05-21 EP disclosed
WO-2023104688-A1 SOLID COMPOSITION GIVAUDAN SA (CH) 2023-06-15 WO disclosed
WO-2023020883-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2023-02-23 WO disclosed
WO-2023017014-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2023-02-16 WO disclosed
CN-110099990-B Perfume mixture 西姆莱斯股份公司 2022-11-29 CN disclosed
CN-115322833-A Perfume mixture 西姆莱斯股份公司 2022-11-11 CN disclosed
WO-2022223569-A1 COMPOSITION FOR TREATING A KERATINOUS SURFACE GIVAUDAN SA (CH) 2022-10-27 WO disclosed
WO-2022214636-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2022-10-13 WO disclosed
WO-2022175314-A1 IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2022-08-25 WO disclosed
CN-114727644-A Flavoring and curing method for smoking material and smoking product prepared by using method 韩国烟草人参公社 2022-07-08 CN disclosed
WO-2022112204-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2022-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387771-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES LCT, LPO, RCC1 FFAR1 44/4885F2RL1 1193/4885FFAR4 368/4885
US-12539261-B2 Encapsulated compositions ALG1, GNE, ILK FFAR1 328/4885F2RL1 1376/4885FFAR4 691/4885
US-20250345251-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS TRPM5, KCNN2, MLEC FFAR1 4509/4885F2RL1 4642/4885FFAR4 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.